FIELD: medicine.
SUBSTANCE: drug preparation for treating tuberculosis contains an active substance isoniaside, and a pharmaceutical carrier tiozol gel with the isoniaside concentration of 5.7-54.5 wt % and the tiozol gel concentration of 45.5-94.3 wt %.
EFFECT: higher clinical effectiveness in tuberculosis and lower toxicity.
2 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING PULMONARY TUBERCULOSIS AT PREDOMINANTLY PRODUCTIVE TYPE OF TISSUE REACTION | 2000 |
|
RU2204409C2 |
METHOD FOR TREATING DIFFERENT FORMS OF PULMONARY TUBERCULOSIS, RESISTANT TO ANTITUBERCULAR CHEMOTHERAPY, AMONG THEM | 2001 |
|
RU2197984C1 |
METHOD FOR TREATING THE CASES OF EXPERIMENTAL TUBERCULOSIS | 2000 |
|
RU2165761C1 |
METHOD OF TREATING PATIENTS WITH TUBERCULOUS EXUDATIVE PLEURITIS | 2012 |
|
RU2491089C1 |
METHOD FOR TREATING THE CASES OF TUBERCULOSIS | 2002 |
|
RU2212240C1 |
METHOD OF TREATING TUBERCULOSIS WITH MULTIPLE DRUG RESISTANCE | 2013 |
|
RU2554753C2 |
PREPARATION FOR TUBERCULOSIS TREATMENT | 1994 |
|
RU2080114C1 |
METHOD OF TREATING PATIENTS WITH CHRONIC FORMS OF PULMONARY TUBERCULOSIS | 2013 |
|
RU2519140C1 |
METHOD OF TREATMENT OF EXPERIMENTAL TUBERCULOSIS | 2001 |
|
RU2207127C1 |
METHOD OF TREATING PATIENTS WITH PULMONARY TUBERCULOSIS WITH ACCOMPANYING NON-SPECIFIC BRONCHITES | 2013 |
|
RU2526121C1 |
Authors
Dates
2014-07-27—Published
2013-02-28—Filed